This revealed a significant reduction of leukemia load (P = 0.05, Fig. 1c), as well as significant prolongation of survival of secondary recipients transplanted with BM from MMP-9-deficient mice with B-ALL (P = 0.01, Fig. 1d). Here, MMP9 is linked to leukemia.